Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Inner Mongolia Furui Medical Science Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Inner Mongolia Furui Medical Science Co FCF Yield % Related Terms
Inner Mongolia Furui Medical Science Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Furui Medical Science Co FCF Yield % Chart
Inner Mongolia Furui Medical Science Co Annual Data
SZSE:300049 vs VRTX, REGN, RVMD: FCF Yield % Comparison
For the Biotechnology subindustry, Inner Mongolia Furui Medical Science Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inner Mongolia Furui Medical Science Co FCF Yield % vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Furui Medical Science Co (SZSE:300049) has a FCF Yield % of 1.60 as of Aug. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Inner Mongolia Furui Medical Science Co and its competitors. This is 15% above median its historical median of 1.39. According to the industry distribution chart, Inner Mongolia Furui Medical Science Co ranks #174 out of 1410 companies in the Biotechnology industry, placing it in the top 12.3%.
Is Inner Mongolia Furui Medical Science Co's FCF Yield % too high?
Inner Mongolia Furui Medical Science Co's current FCF Yield % of 1.60 is 15% above median its 10-year median of 1.39. Based on the distribution chart, Inner Mongolia Furui Medical Science Co ranks #174 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Inner Mongolia Furui Medical Science Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Inner Mongolia Furui Medical Science Co's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Inner Mongolia Furui Medical Science Co ranks #174 out of 1410 companies for FCF Yield %. This places Inner Mongolia Furui Medical Science Co in the top 12% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Inner Mongolia Furui Medical Science Co and its competitors. Inner Mongolia Furui Medical Science Co's current FCF Yield % is 1.60, which is 15% above median its own 10-year median of 1.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inner Mongolia Furui Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Inner Mongolia Furui Medical Science Co (SZSE:300049) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥65.97, compared to a current price of ¥43.94 — trading 33.4% below its estimated fair value. The current FCF Yield % is 1.60, which is 15% above median its 10-year median of 1.39. Inner Mongolia Furui Medical Science Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Inner Mongolia Furui Medical Science Co (SZSE:300049), the current FCF Yield % is 1.60 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inner Mongolia Furui Medical Science Co (SZSE:300049) Overvalued in 2026?
Based on GuruFocus' analysis, Inner Mongolia Furui Medical Science Co stock appears to be undervalued.
The current stock price of ¥43.94 is trading 33.4% below its estimated GF Value™ of ¥65.97.
GuruFocus considers Inner Mongolia Furui Medical Science Co to be Significantly Undervalued.
Key valuation signals for SZSE:300049:
FCF Yield %: 1.60 (15% above median its 10-year median of 1.39)
GF Value™: ¥65.97 vs. price of ¥43.94 (33.4% below fair value)
No single metric tells the full story. See the SZSE:300049 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
81GF Score
Get the complete analysis for SZSE:300049
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:300049 has been successfully added to your 
